Lttl vs RxSpan MD

Choose Lttl if…

• +About $1,701 a year less than RxSpan MD for compounded semaglutide at standing prices (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
• +Accepts FSA/HSA cards
• +Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout

What to weigh up

• −No published state list; confirm yours at signup
• −Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
• −Headline 'Plans start at' prices ($89 semaglutide, $139 tirzepatide) are 12-month prepay rates; month-to-month is $99 and $149

Choose RxSpan MD if…

• +Lists oral compounded tirzepatide, brand-name Wegovy / Ozempic and brand-name Zepbound / Mounjaro, which Lttl doesn't price
• +Publishes its full state list (50 states)
• +Physician-led — founded by Dr. John Diaz, a board-certified plastic surgeon with 20+ years' experience

What to weigh up

• −About $1,701 a year more than Lttl for compounded semaglutide (one bills every 4 weeks (13 charges a year), so this compares modeled yearly cost)
• −Compounded pricing ($249 semaglutide / $329 tirzepatide) sits mid-to-high versus the cheapest telehealth options
• −Brand-name GLP-1 is priced steeply (Wegovy $1,349, Ozempic $1,299, Zepbound $1,069)